When and how should 25% albumin be administered to a hypotensive septic shock patient who has already received at least 30 mL/kg balanced crystalloid and has hypo‑albuminemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

25% Albumin Administration in Hypotensive Septic Shock with Hypoalbuminemia

Consider administering 25% albumin in addition to crystalloids when your septic shock patient remains hypotensive after receiving at least 30 mL/kg balanced crystalloid and has documented hypoalbuminemia (albumin <3.0 g/dL).

Guideline-Based Recommendation

The 2016 Surviving Sepsis Campaign guidelines suggest using albumin in addition to crystalloids for initial resuscitation and subsequent intravascular volume replacement when patients require substantial amounts of crystalloids (weak recommendation, low quality of evidence) 111. Crystalloids remain the first-line fluid of choice (strong recommendation), but albumin serves as an adjunctive therapy in this specific clinical context.

The 2024 International Collaboration for Transfusion Medicine Guidelines acknowledges that while substantial RCT evidence shows little mortality benefit from albumin across broad critically ill populations, the guidelines note that benefits have not been excluded due to wide confidence intervals in sepsis-specific analyses 2. The Surviving Sepsis Campaign explicitly states that "lack of proven benefit and higher cost of albumin compared to crystalloid contributed to our strong recommendation for the use of crystalloids as first-line fluid" but still supports albumin use when large crystalloid volumes are needed 2.

When to Administer: Timing Considerations

Administer 25% albumin after the initial 30 mL/kg crystalloid bolus has been given and the patient remains hypotensive or requires ongoing vasopressor support. Recent evidence suggests early administration of hyperoncotic albumin (20-25%) following initial crystalloid resuscitation may improve mortality outcomes 3. One retrospective study found that timely albumin infusion (within 24 hours of documented albumin <3.0 g/dL) was associated with lower in-hospital mortality compared to delayed or no albumin administration, though this should be interpreted cautiously due to potential confounding 4.

The key clinical scenario is: patient has received ≥30 mL/kg crystalloid, remains hypotensive or on vasopressors, and has documented hypoalbuminemia.

How to Administer: Practical Dosing

Administer 25% albumin at 50-100 mL (12.5-25 g) intravenously over 30-60 minutes, monitoring for hemodynamic response and signs of fluid overload.

According to FDA labeling, 25% albumin is hyperoncotic and will expand plasma volume by 3-4 times the volume administered by drawing fluid from interstitial spaces 5. For hypoproteinemia in sepsis/ICU patients, the usual adult dose is 50-75 g daily 5. The target is to maintain plasma albumin concentration around 2.5 ± 0.5 g/dL with plasma oncotic pressure of 20 mm Hg 5.

Administration specifics:

  • Rate: Do not exceed 2 mL/minute in hypoproteinemic patients to avoid circulatory overload and pulmonary edema 5
  • Dilution: May be given undiluted or diluted in 0.9% NaCl or 5% dextrose; if sodium restriction needed, use 5% dextrose only 5
  • Monitoring: Watch for hemodynamic improvement using dynamic (pulse pressure variation, stroke volume variation) or static (MAP, heart rate) variables 11

Critical Caveats and Pitfalls

Do not use 25% albumin as initial resuscitation fluid—crystalloids must come first. The guidelines are explicit that crystalloids are first-line 111.

Avoid in dehydrated patients without adequate interstitial fluid. The hyperoncotic nature of 25% albumin requires adequate interstitial hydration to draw fluid from; otherwise, additional crystalloids must be given or 5% albumin should be used instead 5.

Monitor closely for circulatory overload. The 3-4x volume expansion effect means 100 mL of 25% albumin can expand plasma volume by 300-400 mL 5. This is particularly dangerous in patients with cardiac dysfunction or those already fluid-overloaded.

Do not exceed 2 g/kg total body weight in the absence of active bleeding 5.

Evidence Nuances

The evidence base shows mixed results. While two recent meta-analyses demonstrated statistically significant reduction in 90-day mortality among septic shock patients resuscitated with albumin versus crystalloid 3, other studies show no difference in vasopressor-free days 6. The 2024 guideline notes that albumin has not shown clear mortality benefit in broad sepsis populations, though subgroup benefits remain possible 2.

Important distinction: Spontaneous increases in serum albumin (without exogenous administration) are associated with better outcomes, but albumin changes in patients receiving human albumin solution do not show the same prognostic association 7. This suggests that simply giving albumin to raise the number may not address the underlying pathophysiology.

The observed association between timely albumin and lower mortality may be confounded by treatment-selection bias, immortal time bias, and residual confounding 4. Patients who receive albumin may differ systematically from those who don't in ways not fully captured by adjustment.

Clinical Algorithm

  1. Initial resuscitation: Give 30 mL/kg balanced crystalloid bolus
  2. Reassess hemodynamics: Check MAP, lactate, perfusion markers
  3. If hypotensive/on vasopressors AND hypoalbuminemic (<3.0 g/dL): Consider 25% albumin 50-100 mL IV over 30-60 minutes
  4. Monitor response: Hemodynamic parameters, fluid balance, signs of overload
  5. Repeat dosing: May give additional doses to target albumin ~2.5 g/dL, not exceeding 50-75 g/day in adults
  6. Concurrent management: Continue source control, antibiotics, vasopressor titration per standard sepsis protocols

The decision to use 25% albumin represents a weak recommendation based on low-quality evidence, but is supported by both guideline consensus and FDA-approved indications for sepsis-related hypoproteinemia 11155.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.